Copyright © Inderes 2011 - present. All rights reserved.
  • Uusimmat
  • Pörssi
    • Aamukatsaus
    • Osakevertailu
    • Pörssikalenteri
    • Osinkokalenteri
    • Analyysi
    • Artikkelit
    • Sisäpiirin kaupat
    • Transkriptit
  • inderesTV
  • Mallisalkku
  • Foorumi
  • Premium
  • Femme
  • Nora AI
  • Opi
    • Sijoituskoulu
    • Q&A
    • Analyysikoulu
  • Meistä
    • Seurantayhtiöt
    • Tiimi
Pörssitiedote

STENOCARE: New Product: More choice for treatment of Swedish patients with medical cannabis oil

Stenocare
Lue tiedote

STENOCARE A/S
NASDAQ FIRST NORTH GROWTH MARKET, DENMARK
TICKER:  STENO

 

STENOCARE A/S ("STENOCARE") and Emerald Health Therapeutics Inc ("Emerald") hereby announces that the first product shipment and delivery of THC-CBD Balanced medical cannabis oil has been completed on February 12, 2021 to Sweden.
 

STENOCARE announced on September 8, that medical cannabis oil from their supplier, Emerald, had been accepted for treatment of Swedish patients. In December 2020, the first THC oil products were delivered, and now the first THC-CBD oil products have been delivered to Sweden. With these two products available for treatment, there is more choice for doctors and patients when considering medical cannabis as a supplement to conventional treatment protocols.

In Sweden, several patients diagnosed with chronic nervous system pain, spasms and nausea from chemotherapy have via their doctor applied for a prescription for treatment with THC-CBD medical cannabis oil.

STENOCARE is a leading supplier of premium prescription-based medical cannabis products for patients' treatment to help them improve quality of life, and for Sweden their Canadian supplier of high-quality medical cannabis products, Emerald, will manufacture and deliver their medical cannabis oil products.

Niels V. Olsen, anesthesiologist, D.M.Sc., at "Smärt och Psykiatri Centrum Malmö" is commenting:

"We have been applying conventional treatment protocols to patients with neuropathic pain and find it relevant to supplement with medical cannabis. We will test how medical cannabis oil can help reduce pain, spasm and enable better mobility for patients with severe chronic pain related to cancer or nerve injuries"

Thomas Skovlund Schnegelsberg, CEO of STEOCARE is commenting:

"With this second type of medical cannabis oil to Sweden there is more choice to doctors and patients. Now they both have a high-THC oil and a balanced THC-CBD oil product available for supplemental treatment"

Sosiaalinen media
  • Inderes Foorumi
  • Youtube
  • Facebook
  • Instagram
  • X (Twitter)
  • Tiktok
  • Linkedin
Yhteystiedot
  • info@inderes.fi
  • +358 10 219 4690
  • Porkkalankatu 5
    00180 Helsinki
Inderes
  • Meistä
  • Tiimi
  • Avoimet työpaikat
  • Inderes sijoituskohteena
  • Palvelut pörssiyhtiöille
Sivusto
  • UKK
  • Käyttöehdot
  • Tietosuojaseloste
  • Vastuuvapauslauseke
Inderesin vastuuvapauslauseke löytyy täältä. Kunkin Inderesin aktiivisessa seurannassa olevan osakkeen tarkemmat tiedot löytyvät kunkin osakkeen omilta yhtiösivuilta Inderes-sivustolla. © Inderes Oyj. Kaikki oikeudet pidätetään.